Bezafibrate
Bezafibrate (marketed as Bezalip and various other brand names) is a fibrate drug used for the treatment of hyperlipidaemia. It helps to lower LDL cholesterol and triglyceride in the blood, and increase HDL.
Starting at
Product Description
| 2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid |
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a682711 |
| Legal status |
UK: POM (Prescription only) US: ℞-only |
| Routes of administration |
Oral |
| CAS Number | 41859-67-0 |
| ATC code | C10AB02 |
| PubChem | CID: 39042 |
| IUPHAR/BPS | 2668 |
| DrugBank | DB01393 |
| ChemSpider | 35728 |
| UNII | Y9449Q51XH |
| KEGG | D01366 |
| ChEBI | CHEBI:47612 |
| ChEMBL | CHEMBL264374 |
| Formula | C19H20ClNO4 |
| Molecular mass | 361.819 g/mol |
|
SMILES[show] |
|
|
InChI[show] |
|
